BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1353540)

  • 1. Buserelin treatment of cryptorchidism: a randomized, double-blind, placebo-controlled study.
    Bica DT; Hadziselimovic F
    J Urol; 1992 Aug; 148(2 Pt 2):617-21. PubMed ID: 1353540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavior of epididymis, processus vaginalis and testicular descent in cryptorchid boys treated with buserelin.
    Bica DT; Hadziselimovic F
    Eur J Pediatr; 1993; 152 Suppl 2():S38-42. PubMed ID: 8101813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone.
    Rajfer J; Handelsman DJ; Swerdloff RS; Hurwitz R; Kaplan H; Vandergast T; Ehrlich RM
    N Engl J Med; 1986 Feb; 314(8):466-70. PubMed ID: 2868413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of luteinizing hormone-releasing hormone analogue (buserelin) on cryptorchid testes.
    Hadziselimović F; Huff D; Duckett J; Herzog B; Elder J; Snyder H; Buser M
    J Urol; 1987 Oct; 138(4 Pt 2):1043-5. PubMed ID: 2888905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of human chorionic gonadotrophin (hCG)/follicle-stimulating hormone treatment versus hCG treatment alone on testicular descent: a double-blind placebo-controlled study.
    Hoorweg-Nijman JJ; Havers HM; Delemarre-van de Waal HA
    Eur J Endocrinol; 1994 Jan; 130(1):60-4. PubMed ID: 7907261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cryptorchidism with human chorionic gonadotropin or gonadotropin releasing hormone. A double-blind controlled study of 243 boys.
    Christiansen P; Müller J; Buhl S; Hansen OR; Hobolth N; Jacobsen BB; Jørgensen PH; Kastrup KW; Nielsen K; Nielsen LB
    Horm Res; 1988; 30(4-5):187-92. PubMed ID: 2907896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LHRH treatment in unilateral cryptorchidism: effect on testicular descent and hormonal response.
    Karpe B; Eneroth P; Ritzén EM
    J Pediatr; 1983 Dec; 103(6):892-7. PubMed ID: 6139422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of cryptorchidism in children: testicular volume and hormonal function at 18 years of age.
    Varela-Cives R; Mendez-Gallart R; Estevez-Martinez E; Rodriguez-Barca P; Bautista-Casasnovas A; Pombo-Arias M; Tojo-Sierra R
    Int Braz J Urol; 2015; 41(1):57-66. PubMed ID: 25928530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of LHRH treatment on testicular descent and hormonal response in cryptorchidism.
    Wit JM; Delemarre-Van de Waal HA; Bax NM; Van den Brande JL
    Clin Endocrinol (Oxf); 1986 May; 24(5):539-48. PubMed ID: 2878745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between adult dark spermatogonia and secretory capacity of Leydig cells in cryptorchidism.
    Zivkovic D; Bica DT; Hadziselimovic F
    BJU Int; 2007 Nov; 100(5):1147-9; discussion 1149. PubMed ID: 17662083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endocrine data in cryptorchism].
    Gendrel D; Job JC; Canlorbe P; Roger M; Laclyde JP
    Arch Fr Pediatr; 1978 May; 35(5):535-45. PubMed ID: 28100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cryptorchidism by intranasal synthetic luteinising-hormone releasing hormone. Results of a collaborative double-blind study.
    Illig R; Exner GU; Kollmann F; Kellerer K; Borkenstein M; Lunglmayr L; Kuber W; Prader A
    Lancet; 1977 Sep; 2(8037):518-20. PubMed ID: 95729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cryptorchidism with low doses of buserelin over a 6-months period.
    Hadziselimovic F; Huff D; Duckett J; Herzog B; Elder J; Snyder H; Buser M
    Eur J Pediatr; 1987; 146 Suppl 2():S56-8. PubMed ID: 2891526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early hormonal and surgical treatment of cryptorchidism.
    Lala R; Matarazzo P; Chiabotto P; Gennari F; Cortese MG; Canavese F; de Sanctis C
    J Urol; 1997 May; 157(5):1898-901. PubMed ID: 9112559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of undescended testes with hMG and hMG plus hCG: clinical, hormonal and sonographic evaluation.
    De Rosa G; Della Casa S; Corsello SM; Colabucci F; Rossodivita A; Ferdinandi A; Cecchini L
    Ann Endocrinol (Paris); 1987; 48(6):468-72. PubMed ID: 2895604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal treatment may harm the germ cells in 1 to 3-year-old boys with cryptorchidism.
    Cortes D; Thorup J; Visfeldt J
    J Urol; 2000 Apr; 163(4):1290-2. PubMed ID: 10737531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy with LHRH and HCG in cryptorchid infants.
    Lala R; Matarazzo P; Chiabotto P; de Sanctis C; Canavese F; Hadziselimovic F
    Eur J Pediatr; 1993; 152 Suppl 2():S31-3. PubMed ID: 8101810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of serum gonadotropins establishes the diagnosis of anorchism in prepubertal boys with bilateral cryptorchidism.
    Jarow JP; Berkovitz GD; Migeon CJ; Gearhart JP; Walsh PC
    J Urol; 1986 Jul; 136(1 Pt 2):277-9. PubMed ID: 2873261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of the non-descended testis: doubtful value of luteinizing-hormone-releasing-hormone (LHRH). A double-blind, placebo-controlled multicentre study.
    Olsen LH; Genster HG; Mosegaard A; Jørgensen FS; Hofman N; Jensen VB; Lassen LB; Rassmussen M; Vinzents L; Dammegaard L
    Int J Androl; 1992 Apr; 15(2):135-43. PubMed ID: 1349301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal treatment of cryptorchidism--hCG or GnRH--a multicentre study.
    Christiansen P; Müller J; Buhl S; Hansen OR; Hobolth N; Jacobsen BB; Jørgensen PH; Kastrup KW; Nielsen K; Nielsen LB
    Acta Paediatr; 1992 Aug; 81(8):605-8. PubMed ID: 1356527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.